Bayer | BAYN - Operating Profit

Stock Price
44.82
Daily Change
-0.33 -0.73%
Monthly
17.82%
Yearly
111.22%
Q1 Forecast
43.25

Bayer reported EUR-543M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Air Liquide EUR 9.5B 7.07B Jun/2025
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 332M 85M Sep/2025
Amarin USD -1.7M 8.47M Sep/2025
Arkema EUR 107M 57M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -543M 556M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
Corteva USD 811M 1.08B Dec/2025
Covestro EUR 5.39B 5.34B Sep/2025
Essilor EUR 2B 1.22B Jun/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Genmab DKK 360M 172M Jun/2025
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Henkel EUR 1.61B 73M Jun/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Johnson Matthey GBP 142M 89M Dec/2025
Linde USD 2.41B 68M Sep/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.21B 180M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Nutrien USD 792M 1.05B Sep/2025
Philips EUR 329M 159M Sep/2025
PPG Industries USD 450M 128M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
SAP EUR 2.78B 1.95B Dec/2025
Solvay EUR 138M 12M Sep/2025
UCB EUR 1B 678M Dec/2024
Umicore EUR 304.3M 959.85M Jun/2025
Vinci EUR 3.8B 1.35B Jun/2025